Implantable medical systems and methods used to detect, characterize or avoid atrial oversensing within an iegm
AssigneePacesetter, Inc.
InventorsYun Qiao, Wenwen Li, Jan Mangual, Luke C. McSpadden
Life of this patent
Estimating the term…
Loading patent…
AssigneePacesetter, Inc.
InventorsYun Qiao, Wenwen Li, Jan Mangual, Luke C. McSpadden
Estimating the term…
Certain embodiments of the present technology described herein relate to detecting atrial oversensing, characterizing atrial oversensing, determining when atrial oversensing is likely to occur, and or reducing the chance of atrial oversensing occurring. Some such embodiments relate to specifying an atrial oversensing avoidance (AOA) period corresponding to when atrial oversensing may occur following one or more paced or sensed atrial events, and after specifying the AOA period selectively using an atrial oversensing avoidance technique during one or more instances of the AOA period that follow paced or sensed atrial events to thereby reduce a likelihood of atrial oversensing during the one or more instances of the AOA period.
A method for use with an implantable medical system, the method comprising:
An implantable medical system comprising:
Dependencies are inferred from the claim text.